Clinical epidemiology of cardiovascular disease in chronic renal disease

American Journal of Kidney Diseases

Volumn 32, Issue 5 SUPPL. 3, 1998, Pages

  Foley, Robert N ^a   Parfrey, Patrick S ^b   Sarnak, Mark J ^b  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b NONE

Author keywords

Epidemiology; Heart failure; Heart hypertrophy; Kidney failure; Myocardial ischemia

Indexed keywords

CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CONGESTIVE HEART FAILURE; CORONARY RISK; HEART HEMODYNAMICS; HEART HYPERTROPHY; HEART MUSCLE ISCHEMIA; HUMAN; REVIEW; RISK FACTOR;

EID: 0031733696     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.1998.v32.pm9820470     Document Type: Review

References (40)

1. The USRDS Dialysis Morbidity and Mortality Study: Wave 2. US Renal Data System. Am J Kidney Dis 30:S67-S85, 1997 (suppl 1).
2. Greaves SC, Gamble GD, Collins JF, Whalley GA, Sharpe DN: Determinants of LVH and systolic dysfunction in chronic renal failure. Am J Kidney Dis 24:768-776, 1994
3. Tucker B, Fabbian F, Giles M, Thuraisingham RC, Raine AE, Baker LR: Left ventricular hypertrophy and ambulatory blood pressure monitoring in chronic renal failure. Nephrol Dial Transplant 12:724-728, 1997
4. Levin A, Singer J, Thompson CR, Ross H, Lewis M: Prevalent LVH in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis 27:347-354, 1996
5. Levin A, Ethier J, Carlisle E, Burgess E, Mendelssohn D, Tobe S, Jindal K, Barrett B, Djurdjev O, Singer J, Thompson C, and Canadian Nephrology Investigators Group: Anemia in renal insufficiency promotes left ventricular growth. J Am Soc Nephrol 7: 1391, 1996 (abstr)
6. Lazarus JM, Bourgoignie JJ, Buckalew VM, Greene T, Levey AS, Milas NC, Paranandi L, Peterson JC, Porush JG, Rauch S, Soucie JM, Stollar C: Achievement and safety of a low blood pressure goal in CRD. The Modification of Diet in Renal Disease Study Group. Hypertension 29:641-650, 1997
7. Maschio G, Alberti D, Janin G, Locatelli F, Mann JFE, Motolese M, Ponticelli C, Ritz E, Zucchelli P: Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 334:939-945, 1996
8. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group. Lancet 349:1857-1863, 1997
9. USRDS Annual Report, Ann Arbor, MI, 1997
10. Silberberg JS, Barre PE, Prichard SS, Sniderman AD: Impact of LVH on survival in end-stage renal disease. Kidney Int 36:286-290, 1989
11. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47:186-192, 1995
12. Covic A, Goldsmith DJ, Georgescu G, Venning MC, Ackrill P: Echocardiographic findings in long-term, long-hour hemodialysis patients. Clin Nephrol 45:104-110, 1996
13. Dahan M, Siohan P, Viron B, Michel C, Paillole C, Gourgon R, Mignon F: Relationship between LVH, myocardial contractility, and load conditions in hemodialysis patients: An echocardiographic study. Am J Kidney Dis 30:780-785, 1997
14. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 5:2024-2031, 1995
15. Perneger TV, Klag MJ, Whelton PK: Cause of death in patients with end-stage renal disease: Death certificates vs registry reports. Am J Public Health 83:1735-1738, 1993
16. Hutchinson TA, Thomas DC, MacGibbon B: Predicting survival in adults with end-stage renal disease: An age equivalence index. Ann Intern Med 96:417-423, 1982
17. US Renal Data System 1992, Annual Report. IV. Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis patients. Am J Kidney Dis 20:32-38, 1992 (suppl 2)
18. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS: Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors. Kidney Int 47:884-890, 1995
19. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray D, Barre P: Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int 49:1428-1434, 1996
20. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE: Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 11: 1277-1285, 1996
21. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 28:53-61, 1996
22. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 49:1379-1385, 1996
23. London GM, Fabiani F, Marchais SJ, de Vernejoul MC, Guerin AP, Safar ME, Metivier F, Llach F: Uremic cardiomyopathy: An inadequate LVH. Kidney Int 31:973-980, 1987
24. Rocco MV, Soucie JM, Reboussin DM, McClellan WM: Risk factors for hospital utilization in chronic dialysis patients. Southeastern Kidney Council (Network 6). J Am Soc Nephrol 7:889-896, 1996
25. Churchill DN, Taylor DW, Cook RJ, LaPlante P, Barre P, Cartier P, Fay WP, Goldstein MB, Jindal K, Mandin H, McKenzie JK, Muirhead N, Parfrey PS, Posen GA, Slaughter D, Ulan RA, Werb R: Canadian Hemodialysis Morbidity Study. Am J Kidney Dis 19:214-234, 1992
26. Manske CL, Wilson RF, Wang Y, Thomas W: Prevalence of, and risk factors for, angiographically determined CAD in type I-diabetic patients with nephropathy. Arch Intern Med 152:2450-2455, 1992
27. Rostand SG, Kirk KA, Rutsky EA: Dialysis-associated ischemic heart disease: Insights from coronary angiography. Kidney Int 25:653-659, 1984
28. Foley RN, Parfrey PS, Harnett JD, Kent GM, O'Dea R, Murray DC, Barre PE: Mode of dialysis therapy and mortality in end-stage renal disease. J Am Soc Nephrol 9:267-276, 1998
29. Bloembergen WE, Port FK, Mauger EA, Wolfe RA: A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 6:184-191, 1995
30. Fenton SS, Schaubel DE, Desmeules M, Morrison HI, Mao Y, Copleston P, Jeffery JR, Kjellstrand CM: Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates. Am J Kidney Dis 30:334-342, 1997
31. Kasiske BL: Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 84:985-992, 1988
32. Parfrey PS, Harnett JD, Foley RN, Kent GM, Murray DC, Barre PE, Guttmann RD: Impact of renal transplantation on uremic cardiomyopathy. Transplantation 60:908-914, 1995
33. Hernandez D, Lacalzada J, Rufino M, Torres A, Martin N, Barragan A, Barrios Y, Macia M, de Bonis E, Lorenzo V, Rodriguez A, Gonzalez-Posada JM, Salido E: Prediction of left ventricular mass changes after renal transplantation by polymorphism of the angiotensin-converting-enzyme gene. Kidney Int 51:1205-1211, 1997
34. Peteiro J, Alvarez N, Calvino R, Penas M, Ribera F, Castro Beiras A: Changes in left ventricular mass and filling after renal transplantation are related to changes in blood pressure: An echocardiographic and pulsed Doppler study. Cardiology 85:273-283, 1994
35. Huting J: Course of LVH and function in end-stage renal disease after renal transplantation. Am J Cardiol 70: 1481-1484, 1992
36. Himelman RB, Landzberg JS, Simonson JS, Amend W, Bouchard A, Merz R, Schiller NB: Cardiac consequences of renal transplantation: Changes in left ventricular morphology and function. J Am Coll Cardiol 12:915-923, 1988
37. Lindholm A, Albrechtsen D, Frodin L, Tufveson G, Persson NH, Lundgren G: Ischemic heart disease - Major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 60:451-457, 1995
38. Manske CL, Wilson RF, Wang Y, Thomas W: Atherosclerotic vascular complications in diabetic transplant candidates. Am J Kidney Dis 29:601-607, 1997
39. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left-ventricular mass in the Framingham Heart Study. N Engl J Med 322:1561-1566, 1990
40. National Heart, Lung and Blood Institutes: Morbidity and Mortality Chartbook. Bethesda, MD, National Heart, Lung and Blood Institute, 1996